Pharm prime vendor fleet
Ended Awarded Last action
- Contract number
- SPE2DU26F0C72
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,080
Award facts
- Contract value 100% obligated
- $3,080.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $3,080.05 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order was issued under DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide. The award carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group holds the underlying indefinite delivery contract (IDC) for this program, valued at $499.999 billion with a completion date of December 31, 2036, positioning the company as one of multiple regional prime vendor contractors within the broader PPV-G GEN V framework.
DMS Pharmaceutical Group supplies an extensive portfolio of pharmaceutical products and medical consumables to support DoD military healthcare operations, including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and surgical products. The company's product range encompasses oncology treatments, immunosuppressants, emergency medications, and routine pharmaceuticals such as antibiotics and antivirals. As the prime contractor, DMS Pharmaceutical Group operates without identified subcontractors on this award. The delivery order represents one of numerous recent awards issued to the contractor by DLA's Medical Supply Chain division, reflecting sustained demand for the company's pharmaceutical distribution capabilities across the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26F0C72?
SPE2DU26F0C72 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 9, 2025.
How much is contract SPE2DU26F0C72 worth?
The government has obligated $3,080 on SPE2DU26F0C72.
Is contract SPE2DU26F0C72 an order under another contract?
Yes. SPE2DU26F0C72 is a delivery order under SPE2DU25D9803, an indefinite delivery contract.
Was contract SPE2DU26F0C72 competed?
The extent of competition for SPE2DU26F0C72 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award